Suppression of cellular immunity in vivo by rifampicin.
D000818:Animals; D001500:BCG Vaccine; D006084:Graft Rejection / Q000187:drug effects; D006168:Guinea Pigs; D006968:Hypersensitivity, Delayed / Q000276:immunology; D007111:Immunity, Cellular / Q000187:drug effects*; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008809:Mice, Inbred C3H; D012293:Rifampin / Q000494:pharmacology*; D012882:Skin Tests; D016038:Skin Transplantation; D014184:Transplantation, Homologous; D014373:Tuberculin
D001500:BCG Vaccine; D007166:Immunosuppressive Agents; D014373:Tuberculin; D012293:Rifampin